Together, we can turn groundbreaking concepts into impactful solutions.

Partnering with government, institutions, foundations, and nonprofits, we tackle pressing health challenges efficiently through the power of collaboration. Our experienced team of experts in science, medicine, engineering, and business work alongside our partners to identify and nurture high-potential health innovation projects. 

The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Moving Ideas Forward

  • Proven Processes: Streamlined methodologies that ensure efficiency and effectiveness. 
  • Hands-On Facilitation: Direct, personalized assistance at every step of the innovation process.
  • Global Network: Access to a world-class network of experts ready to lend insights and experience.
  • Customized Tools: Tailored infrastructure, tools, and resources designed to fit the needs of your project.  

     

Where We Excel

  • Spotting highly promising projects.
  • Engaging the world’s leading experts.
  • Minimizing risk through our Deep Dive evaluation.
  • Maximizing speed and efficiency with the support of tailored tools.
  • Accelerating development through our proven process.

 

 

Our Impact

We have supported more than 1,200 innovator teams, evaluated more than 5,000 ideas, and helped develop more than a thousand health innovations. Our efforts have resulted in:

  • 49% commercialization success rate.
  • $2 billion in follow-on funding.
  • 1000+ healthcare innovations developed.
  • touching millions of lives.

 

Innovation Spotlight

Innovation Spotlight

Best Practices Resource for Developing COVID-19 Diagnostic Tests

Best Practices Resource for Developing COVID-19 Diagnostic Tests

NIBIB’s RADx® Tech program, along with its collaborators, is working to develop at-home diagnostic tests for COVID-19 that are accessible to everyone. The initial focus has been on meaningfully improving access for those with no or low vision, people with reduced dexterity or motor skills, and those who are aging. 


Throughout this effort, information gathered from end-users, developers, and experts was used to draft a best practices resource to help improve device design and create more accessible tests. 

An abridged version of Best Practices for the Design of Accessible COVID-19 Home Tests, released in 2022, included a limited set of topics. This 2023 publication, which replaces the abridged version, significantly expands upon the previous resource, and strives to facilitate complete solutions from product acquisition through results & disposal.


While this resource is aimed at best practices for the design of COVID-19 home tests, many of these ergonomic and accessible design recommendations are transferable to home tests for other conditions and diseases.  And while this initiative has concentrated on improvements that will improve access for people with disabilities, many of these recommendations will increase ease-of-use for all users. 

 

Learn More >>